pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,405 catalysts · 3,350 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-03-04×clear all
type
  • 8k filing3,350
  • grant1,080
  • device adverse event1,000
  • earnings579
  • approval519
  • device 510k408
device pma
236
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 2, 2026

    7
    ›Mar 6, 2026grant162d agoUNIVERSITY OF OREGON — Responsive and Targeted Modulation of Reactive Sulfur Species

    GM grant. $398,464. PI: Michael Pluth

    full page →nih reporter ↗
    ›Mar 6, 2026grant162d agoUNIVERSITY OF PENNSYLVANIA — Molecular determinants of voltage-gated ion channels' localization and functionUniversity of Pennsylvania

    GM grant. $446,875. PI: Natali L Chanaday Ricagni

    full page →nih reporter ↗
    ›Mar 6, 2026grant162d agoUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — Regulation of ER-phagy during cellular stresses

    GM grant. $429,000. PI: Yang Liu

    full page →nih reporter ↗
    ›Mar 6, 2026grant162d agoSTANFORD UNIVERSITY — Dissecting the molecular mechanisms of membrane protein complex assemblyStanford University

    GM grant. $423,500. PI: Tino Pleiner

    full page →nih reporter ↗
    ›Mar 7, 2026grant161d agoUNIVERSITY OF WASHINGTON — Population Genomics Screening Network (PGSN) Coordinating CenterUniversity of Washington

    HG grant. $2,114,800. PI: Kenneth M. Rice

    full page →nih reporter ↗
    ›Mar 7, 2026grant161d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Exploiting RNA biogenesis to accelerate neuronal maturation and model age-rel...

    NS grant. $126,900. PI: Brian Jude Joseph

    full page →nih reporter ↗
    ›Mar 8, 2026device 510k160d agoOnera B.V. — Onera SleepMap (SLEEPMAP) (510k cleared)

    Product code: OLZ. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗

    Week of Mar 9, 2026

    43
    ›Mar 9, 2026approval159d agoOXCARBAZEPINE — FDA approvalRiconpharma LLC

    Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 9, 2026approval
    ← prev
    page 5 of 149
    next →
    159d ago
    ATROPINE SULFATE — FDA approvalATROPINE SULFATE

    Sponsor: APOTEX. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →ATROPINE SULFATE →fda approvals ↗
    ›Mar 9, 2026approval159d agoBISOPROLOL FUMARATE — FDA approvalBISOPROLOL FUMARATE

    Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

    full page →BISOPROLOL FUMARATE →fda approvals ↗
    ›Mar 9, 2026approval159d agoSODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (SODIUM CHLORIDE) — FDA approvalRevalesio Corp

    Sponsor: B BRAUN. Form: SOLUTION. Route: IRRIGATION

    full page →fda approvals ↗
    ›Mar 9, 2026approval159d agoFAMOTIDINE — FDA approvalKenvue Inc.

    Sponsor: CONTRACT PHARMACAL. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 9, 2026approval159d agoIVERMECTIN — FDA approvalMedinCell SA

    Sponsor: E5 PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 9, 2026approval159d agoWELLCOVORIN (LEUCOVORIN CALCIUM) — FDA approvalLEUCOVORIN CALCIUM

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →LEUCOVORIN CALCIUM →fda approvals ↗
    ›Mar 9, 2026approval159d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

    Sponsor: KNACK. Form: INJECTABLE. Route: INJECTION

    full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 9, 2026approval159d agoQUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: NEXTWAVE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 9, 2026device 510k159d agoSynthes GmbH — DePuy Synthes VOLT™ Proximal Tibia 3.5 Plating System (510k cleared)

    Product code: HRS. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 9, 2026device 510k159d agoFujifilm Corporation — FUJIFILM Endoscope Model ED-S100TP; FUJIFILM Endoscope Model ED-S100XP; FUJIFILM Processor Model VS-1000 (510k cleared)Fujifilm Holdings Corp

    Product code: FDT. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 9, 2026device 510k159d agoShenzhen Root Innovation Technology Co., Ltd. — Momcozy Wearable Breast Pump (BP380, BP380-A, BP380-B, BP380-C, M5, M5-A, M5-B, M5-C) (510k cleared)Hang Feng Technology Innovation Co., Ltd.

    Product code: HGX. Advisory committee: Obstetrics/Gynecology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 9, 2026device 510k159d agoWEBEST Biotech,, LLC — Webest Multi-Drug Urine Cup; Webest Home Multi-Drug Urine Cup (510k cleared)

    Product code: NFT. Advisory committee: Clinical Toxicology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 9, 2026device 510k159d agoMedicell Healthcare Co.,LTD — Medicell Mycosis Laser (MCML24004) (510k cleared)NVP Healthcare Co Ltd

    Product code: PDZ. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 9, 2026device 510k159d agoZimmer, Inc. — Persona the Personalized Knee System (Persona Porous Plasma Spray PPS Femurs) (510k cleared)

    Product code: MBH. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 9, 2026device 510k159d agoS&M Medical Co., Ltd. — NeoSculpt Plus (510k cleared)

    Product code: PBX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 9, 2026device 510k159d agoQIAGEN GmbH — QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B (510k cleared)

    Product code: PCH. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 9, 2026device 510k159d agoArthrex, Inc. — FiberTape Button (510k cleared)

    Product code: MBI. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Mar 9, 2026device 510k159d agoPerspectum, Ltd. — LiverMultiScan (v6.0) (510k cleared)

    Product code: LNH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 9, 2026device pma159d agoCook, Inc. — Zenith Flex AAA Endovascular System and Zenith Iliac Branch (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 9, 2026device pma159d agoW. L. Gore & Associates, Inc. — GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 9, 2026device pma159d agoBoston Scientific Corporation — Axonics Sacral Neuromodulation System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 135 Review Track For 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Mar 9, 2026device pma159d agoBoston Scientific Corporation — Axonics Sacral Neuromodulation System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 135 Review Track For 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Mar 9, 2026device pma159d agoMedtronic, Inc. — OmniaSecure™ MRI SureScan™ Lead Model 3930M (PMA supplement)Medtronic plc

    Supplement type: Normal 180 Day Track. Product code: NVY. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Mar 9, 2026device pma159d agoTransMedics, Inc. — Organ Care System (OCS™) Liver (PMA supplement)TransMedics Group, Inc.

    Supplement type: Normal 180 Day Track No User Fee. Product code: QQK. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Mar 9, 2026device pma159d agoW. L. Gore & Associates, Inc. — GORE® TAG® Conformable Thoracic Endoprosthesis (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 9, 2026device pma159d agoW. L. Gore & Associates, Inc. — GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 9, 2026grant159d agoUNIVERSITY OF MISSOURI KANSAS CITY — Gene-regulatory mechanisms of neuronal circuit formation in Drosophila

    NS grant. $137,687. PI: Jelly Hubertus Maria Soffers

    full page →nih reporter ↗
    ›Mar 9, 2026grant159d agoPENNSYLVANIA STATE UNIVERSITY, THE — Evolving together, evolving apart: probing the genomic basis of a facultative...

    GM grant. $393,250. PI: Liana Twardosz Burghardt

    full page →nih reporter ↗
    ›Mar 9, 2026grant159d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — A Program Investigating New Concepts ofMacrophage Biology in Atherosclerosis ...

    HL grant. $1,151,500. PI: Ira A Tabas

    full page →nih reporter ↗
    ›Mar 9, 2026grant159d agoUNIVERSITY OF WASHINGTON — High-throughput and Machine Learning Optimization of Fluorescent Sensors for ...University of Washington

    MH grant. $2,305,031. PI: Andre Berndt

    full page →nih reporter ↗
    ›Mar 9, 2026grant159d agoUNIVERSITY OF CALIFORNIA BERKELEY — Site-specific Non-LTR Retrotransposon Mechanisms of Mobility and Transgene In...

    GM grant. $617,574. PI: Kathleen Collins

    full page →nih reporter ↗
    ›Mar 9, 2026grant159d agoUNIVERSITY OF GEORGIA — Role of CTCF in Nucleotide Excision Repair

    GM grant. $300,872. PI: Wentao Li

    full page →nih reporter ↗
    ›Mar 10, 2026approval158d agoKARBINAL ER (CARBINOXAMINE MALEATE) — FDA approvalAYTU BIOPHARMA, INC

    Sponsor: AYTU. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 10, 2026approval158d agoARCALYST (RILONACEPT) — FDA approvalrilonacept

    Sponsor: KINIKSA PHARMACEUTICALS (UK), LTD.. Form: VIAL. Route: SINGLE-USE

    full page →rilonacept →fda approvals ↗
    ›Mar 10, 2026approval158d agoQUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: NEXTWAVE PHARMS. Form: TABLET, EXTENDED RELEASE, CHEWABLE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 10, 2026approval158d agoDESVENLAFAXINE SUCCINATE — FDA approvaldesvenlafaxine succinate ER

    Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →desvenlafaxine succinate ER →fda approvals ↗
    ›Mar 10, 2026approval158d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: INNOGENIX. Form: TABLET. Route: ORAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Mar 10, 2026approval158d agoDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalDoxil

    Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION

    full page →Doxil →fda approvals ↗
    ›Mar 10, 2026approval158d agoALEVE (NAPROXEN SODIUM) — FDA approvalNAPROXEN SODIUM

    Sponsor: BAYER. Form: TABLET. Route: ORAL

    full page →NAPROXEN SODIUM →fda approvals ↗
    ›Mar 10, 2026approval158d agoADAPALENE — FDA approvalPL Developments Copiague LLC

    Sponsor: P AND L. Form: GEL. Route: TOPICAL

    full page →fda approvals ↗
    ›Mar 10, 2026approval158d agoOGSIVEO (NIROGACESTAT HYDROBROMIDE) — FDA approvalnirogacestat hydrobromide

    Sponsor: SPRINGWORKS. Form: TABLET. Route: ORAL

    full page →nirogacestat hydrobromide →fda approvals ↗
    ›Mar 10, 2026approval158d agoMESALAMINE — FDA approvalDifGen Pharmaceuticals LLC

    Sponsor: DIFGEN PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    $KVUE19.200.00%
    $FOFO3.0000+2.39%
    $COLL28.23+0.28%
    $MDT91.27+0.76%
    $TMDX69.43-2.72%
    $AYTU2.2300-0.89%
    $BSX51.83+0.27%
    $BSX51.83+0.27%
    $COLL28.23+0.28%